Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 7-8/2017

01.05.2017 | main topic

Mechanisms on spasmolytic and anti-inflammatory effects of a herbal medicinal product consisting of myrrh, chamomile flower, and coffee charcoal

verfasst von: Dr. Cica Vissiennon, Karl-Heinz Goos, Jürgen Arnhold, Karen Nieber

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 7-8/2017

Einloggen, um Zugang zu erhalten

Summary

Inflammatory bowel disease or irritable bowel syndrome are chronic gastrointestinal disorders which are associated with a lifelong therapeutic need. The disease results in physical, psychological, and social problems with an impact on partnership, sexuality, education, and career. Thus, the number of patients and health care professionals relying on traditional and complementary medicines and especially phytotherapy for the treatment of these chronic conditions is increasing over recent years. One traditional herbal medicinal product consisting of chamomile flower, myrrh, and coffee charcoal has been widely used in clinical practice within this indication area. Long-term experience and an increasing understanding of the pharmacological mechanisms substantiate its application and clinical effectiveness. Mainly the spasmolytic and anti-inflammatory effects provide a rationale for its therapeutic application. In addition, synergistic effects between the herbal components contribute to the overall effect of this medication.
Literatur
1.
Zurück zum Zitat Vind I, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101(6):1274–82.CrossRefPubMed Vind I, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003–2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101(6):1274–82.CrossRefPubMed
2.
Zurück zum Zitat Sina C, et al. The German competence network inflammatory bowel disease (KNCED) – network research leads to the identification of the cause of disease and to the improvement in patient care. Med Klin (Munich). 2006;101(2):161–5.CrossRef Sina C, et al. The German competence network inflammatory bowel disease (KNCED) – network research leads to the identification of the cause of disease and to the improvement in patient care. Med Klin (Munich). 2006;101(2):161–5.CrossRef
3.
Zurück zum Zitat Knoflach P. Chronisch entzündliche Darmerkrankungen: Neues zur Ätiopathogenese. J Gastroenterol Hepatol Erkrank. 2014;12(3):7–10. Knoflach P. Chronisch entzündliche Darmerkrankungen: Neues zur Ätiopathogenese. J Gastroenterol Hepatol Erkrank. 2014;12(3):7–10.
4.
5.
Zurück zum Zitat Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis. 2000;6(1):21–33.CrossRefPubMed Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis. 2000;6(1):21–33.CrossRefPubMed
7.
Zurück zum Zitat Moser G. Bedeutung von Stress und Depression bei chronisch entzündlichen Darmerkrankungen. J Gastroenterol Hepatol Erkrank. 2015;3(2):26–30. Moser G. Bedeutung von Stress und Depression bei chronisch entzündlichen Darmerkrankungen. J Gastroenterol Hepatol Erkrank. 2015;3(2):26–30.
8.
Zurück zum Zitat Langhorst J, et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohns Colitis. 2015;9(1):86–106.CrossRefPubMed Langhorst J, et al. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohns Colitis. 2015;9(1):86–106.CrossRefPubMed
9.
Zurück zum Zitat Hilsden RJ, et al. Use of complementary and alternative medicine by patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2011;17(2):655–62.CrossRefPubMed Hilsden RJ, et al. Use of complementary and alternative medicine by patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2011;17(2):655–62.CrossRefPubMed
10.
Zurück zum Zitat Ng SC, et al. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(8):854–63.CrossRefPubMed Ng SC, et al. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013;38(8):854–63.CrossRefPubMed
11.
Zurück zum Zitat Wagner H. Multitarget therapy – the future of treatment for more than just functional dyspepsia. Phytomedicine. 2006;13:122–9.CrossRefPubMed Wagner H. Multitarget therapy – the future of treatment for more than just functional dyspepsia. Phytomedicine. 2006;13:122–9.CrossRefPubMed
12.
Zurück zum Zitat Albrecht U, et al. Efficacy and safety of a herbal medicinal product containing myrrh, chamomile and coffee charcoal for the treatment of gastrointestinal disorders: a non-interventional study. BMJ Open Gastroenterol. 2014;1(1):e000015. doi:10.1136/bmjgast-2014-000015.CrossRefPubMed Albrecht U, et al. Efficacy and safety of a herbal medicinal product containing myrrh, chamomile and coffee charcoal for the treatment of gastrointestinal disorders: a non-interventional study. BMJ Open Gastroenterol. 2014;1(1):e000015. doi:10.​1136/​bmjgast-2014-000015.CrossRefPubMed
13.
Zurück zum Zitat Stange R, et al. Günstiger Verlauf einer schweren Colitis ulcerosa. Forsch Komplementmed. 2004;5(6):296–9.CrossRef Stange R, et al. Günstiger Verlauf einer schweren Colitis ulcerosa. Forsch Komplementmed. 2004;5(6):296–9.CrossRef
14.
Zurück zum Zitat Gruia FS. Das Phytotherapeutikum Myrrhinil-Intest® bei unspezifischen Darmerkrankungen. Erfahrungsheilkunde. 1987;2:77–82. Gruia FS. Das Phytotherapeutikum Myrrhinil-Intest® bei unspezifischen Darmerkrankungen. Erfahrungsheilkunde. 1987;2:77–82.
15.
Zurück zum Zitat Langhorst J, et al. Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis – a double-blind, double-dummy study. Aliment Pharmacol Ther. 2013;38(5):490–500.CrossRefPubMed Langhorst J, et al. Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis – a double-blind, double-dummy study. Aliment Pharmacol Ther. 2013;38(5):490–500.CrossRefPubMed
16.
Zurück zum Zitat Malykhina AP, Akbarali HI. Inflammation-induced “channelopathies” in the gastrointestinal smooth muscle. Cell Biochem Biophys. 2004;41(2):319–30.CrossRefPubMed Malykhina AP, Akbarali HI. Inflammation-induced “channelopathies” in the gastrointestinal smooth muscle. Cell Biochem Biophys. 2004;41(2):319–30.CrossRefPubMed
17.
Zurück zum Zitat Srinath AI, et al. Pain management in patients with inflammatory bowel disease: insights for the clinician. Therap Adv Gastroenterol. 2012;5(5):339–57.CrossRefPubMedPubMedCentral Srinath AI, et al. Pain management in patients with inflammatory bowel disease: insights for the clinician. Therap Adv Gastroenterol. 2012;5(5):339–57.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Vissiennon C. In vitro studies on the mechanisms of action of chamomile, myrrh and coffee charcoal: components of a traditional herbal medicinal product (Myrrhinil-Intest®). Dissertation. Leipzig: Universität Leipzig; 2014. Vissiennon C. In vitro studies on the mechanisms of action of chamomile, myrrh and coffee charcoal: components of a traditional herbal medicinal product (Myrrhinil-Intest®). Dissertation. Leipzig: Universität Leipzig; 2014.
19.
Zurück zum Zitat Pumnea T, et al. The herbal extracts of Myrrh, Chamomile and Coffee Charcoal modulate intestinal neurotransmission and motility in murine small intestine. Phytomedicine in preparation Pumnea T, et al. The herbal extracts of Myrrh, Chamomile and Coffee Charcoal modulate intestinal neurotransmission and motility in murine small intestine. Phytomedicine in preparation
20.
Zurück zum Zitat Schilcher H. Die Kamille. Handbuch für Ärzte, Apotheker und andere Naturwissenschaftler. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1987. Schilcher H. Die Kamille. Handbuch für Ärzte, Apotheker und andere Naturwissenschaftler. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1987.
21.
Zurück zum Zitat Achterrath-Tuckermann U, et al. Pharmakologische Untersuchungen von Kamillen-Inhaltsstoffen. Planta Med. 1980;39(05):38–50.CrossRefPubMed Achterrath-Tuckermann U, et al. Pharmakologische Untersuchungen von Kamillen-Inhaltsstoffen. Planta Med. 1980;39(05):38–50.CrossRefPubMed
22.
Zurück zum Zitat Mehmood MH, et al. Antidiarrhoeal, antisecretory and antispasmodic activities of Matricaria chamomilla are mediated predominantly through K(+)-channels activation. BMC Complement Altern Med. 2015;15:75.CrossRefPubMedPubMedCentral Mehmood MH, et al. Antidiarrhoeal, antisecretory and antispasmodic activities of Matricaria chamomilla are mediated predominantly through K(+)-channels activation. BMC Complement Altern Med. 2015;15:75.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Sebai H, et al. Antidiarrheal and antioxidant activities of chamomile (Matricaria recutita L.) decoction extract in rats. J Ethnopharmacol. 2014;152(2):327–32.CrossRefPubMed Sebai H, et al. Antidiarrheal and antioxidant activities of chamomile (Matricaria recutita L.) decoction extract in rats. J Ethnopharmacol. 2014;152(2):327–32.CrossRefPubMed
24.
Zurück zum Zitat Vissiennon C, et al. Calcium antagonistic effects of ethanolic myrrh extract in inflamed intestinal smooth muscle preparations. Planta Med. 2013; doi:10.1055/s-0033-1351895. Vissiennon C, et al. Calcium antagonistic effects of ethanolic myrrh extract in inflamed intestinal smooth muscle preparations. Planta Med. 2013; doi:10.​1055/​s-0033-1351895.
25.
Zurück zum Zitat Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg. 1998;22(4):382–9.CrossRefPubMed Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg. 1998;22(4):382–9.CrossRefPubMed
26.
Zurück zum Zitat Al-Hindawi MK, et al. Anti-inflammatory activity of some Iraqi plants using intact rats. J Ethnopharmacol. 1989;26(2):163–8.CrossRefPubMed Al-Hindawi MK, et al. Anti-inflammatory activity of some Iraqi plants using intact rats. J Ethnopharmacol. 1989;26(2):163–8.CrossRefPubMed
27.
Zurück zum Zitat Gerritsen ME, et al. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol. 1995;147(2):278.PubMedPubMedCentral Gerritsen ME, et al. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol. 1995;147(2):278.PubMedPubMedCentral
28.
Zurück zum Zitat Della Loggia R, et al. Evaluation of the anti-inflammatory activity of chamomile preparations. Planta Med. 1990;56(06):657–8.CrossRef Della Loggia R, et al. Evaluation of the anti-inflammatory activity of chamomile preparations. Planta Med. 1990;56(06):657–8.CrossRef
29.
Zurück zum Zitat Tubaro A, et al. Evaluation of antiinflammatory activity of a chamomile extract topical application. Planta Med. 1984;50(4):359.CrossRef Tubaro A, et al. Evaluation of antiinflammatory activity of a chamomile extract topical application. Planta Med. 1984;50(4):359.CrossRef
30.
Zurück zum Zitat Bhaskaran N, et al. Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity. Int J Mol Med. 2010;26(6):935–40.PubMedPubMedCentral Bhaskaran N, et al. Chamomile: an anti-inflammatory agent inhibits inducible nitric oxide synthase expression by blocking RelA/p65 activity. Int J Mol Med. 2010;26(6):935–40.PubMedPubMedCentral
31.
Zurück zum Zitat Menghini L, et al. An hydroalcoholic chamomile extract modulates inflammatory and immune response in HT29 cells and isolated rat colon. Phytother Res. 2016;30(9):1513–8.CrossRefPubMed Menghini L, et al. An hydroalcoholic chamomile extract modulates inflammatory and immune response in HT29 cells and isolated rat colon. Phytother Res. 2016;30(9):1513–8.CrossRefPubMed
32.
Zurück zum Zitat Srivastava JK, Pandey M, Gupta S. Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity. Life Sci. 2009;85(19–20):663–9.CrossRefPubMedPubMedCentral Srivastava JK, Pandey M, Gupta S. Chamomile, a novel and selective COX-2 inhibitor with anti-inflammatory activity. Life Sci. 2009;85(19–20):663–9.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Ammon HP, Sabieraj J, Kaul R. Kamille. Mechanismus der antiphlogistischen Wirkung von Kamillenextrakten und -inhaltsstoffen. Dtsch Apoth Ztg. 1996;136:1821–34. Ammon HP, Sabieraj J, Kaul R. Kamille. Mechanismus der antiphlogistischen Wirkung von Kamillenextrakten und -inhaltsstoffen. Dtsch Apoth Ztg. 1996;136:1821–34.
34.
Zurück zum Zitat Rocha NFM, et al. Anti-nociceptive and anti-inflammatory activities of (−)-alpha-bisabolol in rodents. Naunyn Schmiedebergs Arch Pharmacol. 2011;384(6):525–33.CrossRefPubMed Rocha NFM, et al. Anti-nociceptive and anti-inflammatory activities of (−)-alpha-bisabolol in rodents. Naunyn Schmiedebergs Arch Pharmacol. 2011;384(6):525–33.CrossRefPubMed
35.
Zurück zum Zitat Vissiennon C, et al. Chamomile flower, myrrh and coffee charcoal, components of a traditional herbal medicinal product, diminish pro-inflammatory activation in human macrophages. Z Phytother. 2016. doi:10.1055/s-0036-1584491. Vissiennon C, et al. Chamomile flower, myrrh and coffee charcoal, components of a traditional herbal medicinal product, diminish pro-inflammatory activation in human macrophages. Z Phytother. 2016. doi:10.​1055/​s-0036-1584491.
36.
Zurück zum Zitat Su S, et al. Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha. J Ethnopharmacol. 2011;134(2):251–8.CrossRefPubMed Su S, et al. Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha. J Ethnopharmacol. 2011;134(2):251–8.CrossRefPubMed
37.
Zurück zum Zitat Su S, et al. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carterii. J Ethnopharmacol. 2012;139(2):649–56.CrossRefPubMed Su S, et al. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carterii. J Ethnopharmacol. 2012;139(2):649–56.CrossRefPubMed
38.
Zurück zum Zitat Tariq M, et al. Anti-inflammatory activity of Commiphora molmol. Agents Actions. 1986;17(3–4):381–2.CrossRefPubMed Tariq M, et al. Anti-inflammatory activity of Commiphora molmol. Agents Actions. 1986;17(3–4):381–2.CrossRefPubMed
39.
Zurück zum Zitat Atta AH, Alkofahi A. Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts. J Ethnopharmacol. 1998;60(2):117–24.CrossRefPubMed Atta AH, Alkofahi A. Anti-nociceptive and anti-inflammatory effects of some Jordanian medicinal plant extracts. J Ethnopharmacol. 1998;60(2):117–24.CrossRefPubMed
40.
Zurück zum Zitat Shalaby MA, Hammouda AA-E. Analgesic, anti-inflammatory and anti-hyperlipidemic activities of Commiphora molmol extract (Myrrh). J Intercult Ethnopharmacol. 2014;3(2):56–62.CrossRefPubMedPubMedCentral Shalaby MA, Hammouda AA-E. Analgesic, anti-inflammatory and anti-hyperlipidemic activities of Commiphora molmol extract (Myrrh). J Intercult Ethnopharmacol. 2014;3(2):56–62.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Fatani AJ, et al. Myrrh attenuates oxidative and inflammatory processes in acetic acid-induced ulcerative colitis. Exp Ther Med. 2016;12(2):730–8.PubMedPubMedCentral Fatani AJ, et al. Myrrh attenuates oxidative and inflammatory processes in acetic acid-induced ulcerative colitis. Exp Ther Med. 2016;12(2):730–8.PubMedPubMedCentral
42.
Zurück zum Zitat Tipton DA, et al. In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol In Vitro. 2003;17(3):301–10.CrossRefPubMed Tipton DA, et al. In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicol In Vitro. 2003;17(3):301–10.CrossRefPubMed
43.
Zurück zum Zitat Tipton DA, Hamman NR, Dabbous MK. Effect of myrrh oil on IL-1beta stimulation of NF-kappaB activation and PGE(2) production in human gingival fibroblasts and epithelial cells. Toxicol In Vitro. 2006;20(2):248–55.CrossRefPubMed Tipton DA, Hamman NR, Dabbous MK. Effect of myrrh oil on IL-1beta stimulation of NF-kappaB activation and PGE(2) production in human gingival fibroblasts and epithelial cells. Toxicol In Vitro. 2006;20(2):248–55.CrossRefPubMed
44.
Zurück zum Zitat Kim M‑S, et al. Myrrh inhibits LPS-induced inflammatory response and protects from cecal ligation and puncture-induced sepsis. Evid Based Complement Alternat Med. 2012;2012(3):1–11. Kim M‑S, et al. Myrrh inhibits LPS-induced inflammatory response and protects from cecal ligation and puncture-induced sepsis. Evid Based Complement Alternat Med. 2012;2012(3):1–11.
45.
Zurück zum Zitat Karp LC, Shanahan F, Targan SR. (editors) Inflammatory bowel disease. From bench to bedside. Norwell: Springer; 2005. Karp LC, Shanahan F, Targan SR. (editors) Inflammatory bowel disease. From bench to bedside. Norwell: Springer; 2005.
46.
Zurück zum Zitat Koshihara Y, et al. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta. 1984;792(1):92–7.CrossRefPubMed Koshihara Y, et al. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta. 1984;792(1):92–7.CrossRefPubMed
47.
Zurück zum Zitat Nardini M, et al. In vitro inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin-rich pine bark (Pinus marittima) extract. Biochim Biophys Acta. 2000;1474(2):219–25.CrossRefPubMed Nardini M, et al. In vitro inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin-rich pine bark (Pinus marittima) extract. Biochim Biophys Acta. 2000;1474(2):219–25.CrossRefPubMed
48.
Zurück zum Zitat Feng R, et al. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem. 2005;280(30):27888–95.CrossRefPubMed Feng R, et al. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem. 2005;280(30):27888–95.CrossRefPubMed
49.
Zurück zum Zitat Yang WS, et al. IRAK1/4-targeted anti-inflammatory action of caffeic acid. Mediators Inflamm. 2013;2013(1):1–12. Yang WS, et al. IRAK1/4-targeted anti-inflammatory action of caffeic acid. Mediators Inflamm. 2013;2013(1):1–12.
50.
Zurück zum Zitat Bone K, Mills S. Principles of herbal pharmacology. In: Bone K, Mills S, editors. Principles and practice of phytotherapy. Amsterdam: Elsevier; 2013. pp. 17–82. Bone K, Mills S. Principles of herbal pharmacology. In: Bone K, Mills S, editors. Principles and practice of phytotherapy. Amsterdam: Elsevier; 2013. pp. 17–82.
51.
Zurück zum Zitat Berenbaum MC. What is synergy? Pharmacol Rev. 1989;41(2):93–141.PubMed Berenbaum MC. What is synergy? Pharmacol Rev. 1989;41(2):93–141.PubMed
52.
Zurück zum Zitat Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55.CrossRefPubMed Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55.CrossRefPubMed
53.
Zurück zum Zitat Fu J, et al. Drug combination in vivo using combination index method. Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice. Synergy. 2016;3(3):15–30.CrossRef Fu J, et al. Drug combination in vivo using combination index method. Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice. Synergy. 2016;3(3):15–30.CrossRef
54.
Zurück zum Zitat Vissiennon C, et al. Synergistic interactions of chamomile flower, myrrh and coffee charcoal in inhibiting pro-inflammatory chemokine release from activated human macrophages. Synergy, in preparation Vissiennon C, et al. Synergistic interactions of chamomile flower, myrrh and coffee charcoal in inhibiting pro-inflammatory chemokine release from activated human macrophages. Synergy, in preparation
55.
Zurück zum Zitat Kopydlowski KM, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol. 1999;163(3):1537–44.PubMed Kopydlowski KM, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol. 1999;163(3):1537–44.PubMed
56.
Zurück zum Zitat Berkman N, et al. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J Immunol. 1995;155(9):4412–8.PubMed Berkman N, et al. Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages. J Immunol. 1995;155(9):4412–8.PubMed
57.
Zurück zum Zitat Carlsen HS, et al. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood. 2004;104(10):3021–7.CrossRefPubMed Carlsen HS, et al. Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis. Blood. 2004;104(10):3021–7.CrossRefPubMed
58.
Zurück zum Zitat Ansel K, Cyster JG. Chemokines in lymphopoiesis and lymphoid organ development. Curr Opin Immunol. 2001;13(2):172–9.CrossRefPubMed Ansel K, Cyster JG. Chemokines in lymphopoiesis and lymphoid organ development. Curr Opin Immunol. 2001;13(2):172–9.CrossRefPubMed
Metadaten
Titel
Mechanisms on spasmolytic and anti-inflammatory effects of a herbal medicinal product consisting of myrrh, chamomile flower, and coffee charcoal
verfasst von
Dr. Cica Vissiennon
Karl-Heinz Goos
Jürgen Arnhold
Karen Nieber
Publikationsdatum
01.05.2017
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 7-8/2017
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-016-0538-y

Weitere Artikel der Ausgabe 7-8/2017

Wiener Medizinische Wochenschrift 7-8/2017 Zur Ausgabe